Extracorporeal life support for pandemic influenza: The role of extracorporeal membrane oxygenation in pandemic management

Journal of Extra-Corporeal Technology

Volumn 42, Issue 4, 2010, Pages 268-280

  DeLaney, Ed ^a   Smith, Michael J ^b   Harvey, Brian T ^b   Pelletier, Keith J ^b   Aquino, Michael P ^b   Stone, Justin M ^b   Jean Baptiste, Gerald C ^b   Johnson, Julie H ^b  

^a LENOX HILL HOSPITAL   (United States)

^b QUINNIPIAC UNIVERSITY   (United States)

Author keywords

Extracorporeal life support; Extracorporeal membrane oxygenation; H1N1; Influenza; Pandemic

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; COMORBIDITY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL OXYGENATION; FATIGUE; FEVER; HEADACHE; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MEDICAL ETHICS; MULTIPLE ORGAN FAILURE; NONHUMAN; NOSE CONGESTION; OXYGEN TENSION; PANDEMIC INFLUENZA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; VOMITING;

EID: 78751521940     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. World Health Organization (WHO). Pandemic (H1N1) 2009-update 86. Available at: http://www.who.int/csr/don/2010-02-5/en/ (Accessed February 11, 2010).
2. Center for Disease Control and Prevention. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April-October 17, 2009. Available at: http://www.cdc.gov/h1n1flu/ estimates/April-October-17. htm (Accessed November 12, 2009).
3. World Health Organization (WHO). World now at the start of 2009 influenza pandemic. Available at: http://www.who.int/mediacentre/news/statements/2009/ h1n1-pandemic-phase6-20090611/en/index.html (Accessed October 8, 2009).
4. Royal College of Physicians. Preparations for pandemic influenza: Guidance for hospital medical specialties on adaptations needed for a pandemic influenza outbreak. Available at: http://bookshop.rcplondon.ac.uk/contents/ f2df511c-f131-4fa1-8b7b-66105a0bb8e4.pdf (Accessed March 14, 2010).
5. Department of Health (DH). Swine flu, guidance for planners (October 22, 2009). Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH-107413 (Accessed March 14, 2010).
6. Ya-Shu C, van Hal SJ, Spencer PM, Gosbell IB, Collett PW. Comparison of adult patients hospitalized with pandemic (H1N1) 2009 influenza and seasonal influenza during the "PROTECT" phase of the pandemic response. Med J Aust. 2010;192:90-3.
7. Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med. 2009;360:2616-25.
8. Malik-Peiris JS, Poon LLM, Guan Y. Emergence of a novels swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol. 2009;45:169-73.
9. Guarner J, Falcon-Escobedo R. Comparison of the Pathology Caused by H1N1, H5N1, and H3N2 Influenza Viruses. Department of pathology and laboratory medicine, Emory University Hospital, Atlanta, GA: Archives of Medical Research; 2010.
10. Bouvier NM, Palese P, Shaw ML. The biology of influenza viruses. Table 1: The genomic segments of influenza A/PuertoRico/8/ 1934 (H1N1) virus and their encoded proteins. Vaccine. 2008;26S:D49-53.
11. Palese P, Shaw ML. Orthomyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM, eds. Fields Virology. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
12. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26S:D49-53.
13. McCance KL, Huether SE. Pathophysiology. The Biological Basis for Disease in Adults and Children, 5th Ed. St. Louis, MO: Elsevier Mosby Inc; 2006:298-305.
14. Patel M, Dennis A, Flutter C, Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth. 2010;104:128-42.
15. Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;361:728-9.
16. Martini FH, Nath JL. Fundamentals of Anatomy and Physiology, 8th Ed. San Francisco, CA: Pearson Education, Inc.; 2009:796-7.
17. Flu.gov. Origin of 2009 H1N1 flu (swine flu): Questions and answers. Available at: http://www.flu.gov/individualfamily/about/h1n1-qa.html (Accessed November 25, 2009).
18. Zebedee SL, Lamb RA. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988;62:2762-72.
19. Matrosovich M, Klenk HD. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol. 2003;13:85-97.
20. Van-Riel D, Munster VJ, de-Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol. 2007;171:1215-23.
21. Couceiro JN, Paulson JC, Baum LG. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 1993;29:155-65.
22. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA. 2004;101:4620-4. (Pubitemid 38437460)
23. Beare AS, Webster RG. Replication of avian influenza viruses in humans. Arch Virol. 1991;119:37-42.
24. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet. 2008;371:1464-75.
25. Prescott LM, Harley JP, Klein DA. Microbiology 6th Ed. New York: McGraw-Hill; 2005:390, 847-9.
26. Stegman T. Membrane fusion mechanisms: The influenza hemagglutinin paradigm and its complications for intracellular fusion. Traffic. 2000;1:598-604.
27. Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell. 1992;69:517-28.
28. Wharton SA, Belshe RB, Skehel JJ, Hay AJ. Role of virion M2 protein in influenza virus uncoating: Specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J Gen Virol. 1994;75:945-8.
29. Cros JF, Palese P. Trafficking of viral genomic RNA into and out of the nucleus: Influenza, Thogoto and Borna disease viruses. Virus Res. 2003;95:3-12.
30. Perez-Padilla R, de-la-Rosa-Zamboni D, Ponce-de-Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680-9.
31. Danziger-Isakov LA, Husain S, Mooney ML, Hannan MH. The novel 2009 H1N1 influenza virus pandemic: Unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant. 2009;28:1341-7.
32. Choi YK, Goyal SM, Kang SW, Farnham MW, Joo HS. Detection and subtyping of swine influenza H1N1, H1N2 and H1N3 viruses in clinical samples using two multiplex RT-PCR assays. J Virol Methods. 2002;102:53-9.
33. Buckley E, Sidebotham D, McGeorge A, Roberts S, Allen SJ, Beca J. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth. 2010;3:326-9.
34. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197-201.
35. World Health Organization (WHO). Pandemic (H1N1) 2009-update 69. Available at: http://www.who.int/csr/don/2009-10-09/en/ (Accessed November 1, 2009).
36. Tsui-Mai K, Chih-Hsien W, Yee-Chun C, et al. The first case of severe novel H1N1 influenza successfully rescued by extracorporeal membrane oxygenation in Taiwan. J Formos Med Assoc. 2009;108:894-8.
37. CDC: WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses. (2010). Available at: http://www.who.int/csr/resources/publications/swineflu/h1n1-guidelines- pharmaceutical-mngt.pdf (Accessed December 2010).
38. Kidd IM, Down J, Nastouli E, et al. H1N1 pneumonitis treated with intravenous zanamivir. Lancet. 2009;374:1035.
39. Baker AJ. What is the role of extracorporeal membrane oxygenation for hypoxic failure during an influenza pandemic? Can J Anaesth. 2010;57:201-5.
40. Center for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:893-6.
41. Daewood F, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15.
42. Center for Disease Control and Prevention. 2009 H1N1 flu. Available at: http://www.cdc.gov/h1n1flu/ (Accessed October 24, 2009).
43. Napolitano LM, Park PK, Raghavendran K, Bartlett RH. Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure. Crit Care Med. 2010;38:S1-17.
44. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-49.
45. 3M Manufacturer. Available at: http://multimedia.3m.com/mws/ mediawebserver?66666UuZjcFSLXTtMXfX4XTEEVuQEcuZgVs6EVs6E666666- (Accessed on November 10, 2010).
46. Ofner-Agostini M, Wallington T, Henry B, et al. Investigation of the second wave (phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened? Can Commun Dis Rep. 2008;2:1-11.
47. Extracorporeal Life Support Organization (ELSO) Ann Arbor, MI. H1N1 Specific Supplements to the ELSO General Guidelines. (2009). Available at: http://www.elso.med.umich.edu/WordForms/ELSO%20H1N1%20Specific%20Guidelines.pdf (Accessed November 12, 2010).
48. Piehl MA, Brown RS. Use of extreme position changes in acute respiratory failure. Crit Care Med. 1976;4:13-4.
49. Gattinoni L, Tognoni G, Pesenti A, et al. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med. 2001;345:568-73.
50. Hoffman GM, Ross RA, Day SE, et al. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med. 1997;25:352-9.
51. Zwissler B, Gregor K, Habler O, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:1671-7.
52. Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Emerging technology review. Extracorporeal Membrane Oxygenation for Treating Severe Cardiac and Respiratory Disease in Adults: Part 1 - Overview of Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth. 2009:23:886-92.
53. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327-36.
54. Adams AB, Simonson DA, Dries DJ. Ventilator-induced lung injury. Respir Care Clin N Am. 2003;9:343-62.
55. Joubert-Huebner E. History of ECMO/ECLS [Powerpoint slides]. Available at: http://www.ecc-book.com/History-of-ECMO-Lecture-1.pdf (Accessed May 2, 2010).
56. ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, Michigan. Available at: http://www.elso.med.umich.edu/H1N1Info.html (Accessed May 27, 2010 ).
57. Zwischenberger BA, Clemson LA, Lynch JE, Zwischenberger JB. ECMO to artificial lungs: Advances in long-term pulmonary support. In: Mongero LB, Beck JR, eds. On Bypass: Advanced Perfusion Techniques. Totowa, NJ: Human Press; 2008:251-77.
58. Meurs KV. ECMO Specialist Training Manual, 2nd Ed. Ann Arbor, MI: Extracorporeal Life Support Organization; 1999: 19, 67, 101, 123-69.
59. University of Michigan Department of Surgery. ECMO. Available at: http://surgery.med.umich.edu/pediatric/research/section/ecmo.shtml (Accessed May 22, 2010).
60. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: A multi-center database. Intensive Care Med. 2009;35:2105-14.
61. Mongero LB, Beck JR, Oz M, Argenziano, M. On Bypass: Advanced Perfusion Techniques. Totowa, NJ: Human Press; 2008:251-77.
62. Peek GJ, Clemens F, Elbourne D, et al. CESAR: Conventional ventilator support vs. extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Services Registry. BMC Health Services Research. 2006;6:163.
63. Grist G, Whittaker C, Merrigan K, Fenton J, Pallotto E, Lofland G. Defining the late implementation of extracorporeal membrane oxygenation (ECMO) by identifying increased mortality risk using specific physiologic cut-points in neonatal and pediatric respiratory patients. J Extra Corpor Technol. 2009;41:213-9.
64. Meurs KV, Lally KP, Peek G, Zwischenberger JB. ECMO Extracorporeal Cardiopulmonary Support in Critical Care, 3rd Ed. Ann Arbor, MI: Extracorporeal Life Support Organization; 2005: 88, 108, 133-51, 364-78, 412-5.
65. Sievert AN, Shackelford AG, McCall MM. Trends and emerging technologies in extracorporeal life support: Results of the 2006 ECLS survey. J Extra Corpor Technol. 2009;41:73-8.
66. Horton S, Thuys C, Bennett M, Augustin S, Rosenberg M, Brizard C. Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO. Perfusion. 2004;19:17-23.
67. Sutton RG, Salatich A, Jegier B, Chabot DA. 2007 survey of extracorporeal life support members: Personnel and equipment. J Extra Corpor Technol. 2009;41:172-9.
68. Schuerer DJE, Kolovos NS, Boyd KV, Coopersmith CM. Extracorporeal membrane oxygenation: Current clinical practice, coding, and reimbursement. American College of Chest Physicians. Chest. 2008;134:179-84.
69. Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: Incidence and risk factors. Crit Care Med. 2005;33:2817-24.
70. Varnholt V, Lasch P, Sartoris J, et al. Prognosis and outcome of neonates treated either with veno-arterial (VA) or veno-venousus (VV) ECMO. Int J Artif Organs. 1995;18:569-73.
71. Huang SC, Yu HY, Ko WJ, Chen YS. Pressure criterion for placement of distal perfusion catheter to prevent limb ischemia during adult extracorporeal life support. J Thorac Cardiovasc Surg. 2004;128:776-7.
72. Khan NU, Al-Aloul M, Shah R, Yonan N. Early experience with the Levitronix Centrimag® device for extra-corporeal membrane oxygenation following lung transplantation. Eur J Cardiothorac Surg. 2008;34:1262-4.
73. Herlihy JP, Loyalka P, Jayaraman G, Kar B, Gregoric ID. Extracorporeal membrane oxygenation using the Tandem Heart System's catheters. Tex Heart Inst J. 2009;36:337-41.
74. Horne DC, Torrance I, Modine T, Gourlay T. The effect of priming solutions and storage time on plasticizer migration in different PVC tubing types - implications for wet storage of ECMO systems. J Extra Corpor Technol. 2009;41:199-205.
75. Kavlock R, Boeckelheide K, Chapin R, et al. NTP Centre for the evaluation of risks to human reproduction: Phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod Toxicol. 2002;16:529-653.
76. Gourlay T, Stefanou DC, Taylor KM. The effect of methanol washing of plasticized polyvinyl chloride on biomaterial-contact-mediated CD11b (mac-1) expression in a rat recirculation model. Artif Organs. 2002;26:5-9.
77. Asberg AE, Videm V. Activation of neutrophil granulocytes in an in vitro model of a cardiopulmonary bypass. Artif Organs. 2005;29:927-36.
78. Pandemic flu information (PFI) (2009). Available at: http://homepage.mac. com/monotreme1/Outbreak%20folder/H1N1Outbreaks.html (Accessed March 24, 2009).
79. World Health Organization (WHO). Preparing for the second wave: Lessons from current outbreaks. Available at: http://www.who.int/csr/disease/swineflu/ notes/h1n1-second-wave-20090828/en/index.html (Accessed November 1, 2009).
80. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A (H1N1) in Canada. Available at: http://jama.amaassn.org/content/ early/2009/10/12/jama.2009.1496.full.pdf (Accessed November 12, 2010).
81. The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888-95. Available at: http://jama.ama-assn.org/cgi/content/full/302/17/1888 (Accessed November 12, 2010).
82. Neale T. Most patients with severe H1N1 treated with ECMO survive. MedPage Today; 2009. Available at: http://www.medpagetoday.com/ InfectiousDisease/URItheFlu/16381 (Accessed November 18, 2009).
83. Elsevier Global Medical News. Flu pandemic pushing demand for ECMO. Available at: http://www.medconnect.com (Accessed October 8, 2009).
84. Gaspard G. Winnipeg surgeon "MacGyvers" artificial lung. Dialysis machine transformed into heart/lung bypass, saves newborn. National Review of Medicine. 2007; Available at: http://www.nationalreviewofmedicine.com/ issue/2007/03-15/4-advances-medicine1-5.html (Accessed November 12, 2010).
85. Lum ME, McMillan AJ, Brook CW, Lester R, Piers LS. Impact of pandemic (H1N1) 2009 influenza on critical care capacity in Victoria. Med J Aust. 2009;191:502-6.
86. Grasselli G, Foti G, Patroniti N, et al. A case of ARDS associated with influenza A-H1N1 infection treated with extracorporeal respiratory support. Minerva Anestesiol. 2009;75:741-5.
87. White DB, Angus DC. Preparing for the sickest patients with 2009 influenza A (H1N1). JAMA. 2009;302:1905-6.
88. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O'Brien CR, Rubenfield GD. Hospital volume and outcomes of mechanical ventilation. N Engl J Med. 2006;355:41-50.
89. Diamond GA, Kaul S. Evidence-based financial incentives for healthcare reform: Putting it together. Circulation: Cardiovas cular Quality and Outcomes. 2009;2:134-40.
90. American Medical Association. 2007 National Physician Fee Schedule Relative Value Units. Chicago, IL: American Medical Association; 2007.
91. Denholm JT, Gordon CL, Johnson PD, et al. Hospitalized adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. The Doctor's Health Fund. Med J Aust. 2010;192:84-6.
92. Morse SS, Garwin RL, Olsiewski PJ. Next flu pandemic: What to do until the vaccine arrives? Science. 2006;314:929.
93. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9-14.
94. Cook D, Burns K, Finfer S, et al. Clinical research ethics for critically ill patients: A pandemic proposal. Crit Care Med. 2010;38:S1-5.
95. Sheu JB. Dynamic relief-demand management for emergency logistics operations under large-scale disasters. Transp Res, Part E Logist Trans Rev. 2010;46:1-17.
96. Sheu JB. An emergency logistics distribution approach for quick response to urgent relief demand in disasters. Transp Res, Part E Logist Trans Rev. 2007;43:687-709.
97. Okie S. Dr. Pou and the hurricane-implications for patient care during disasters. N Engl J Med. 2008;358:1-5.
98. Chan V, Fraser R. ECMO and the elephant in the corner. Perfusion. 2009;24:223-4.
99. Toner E, Waldhorn R, Maldin B, et al. Hospital preparedness for pandemic influenza. Biosecur Bioterror. 2006;4:207-17.
100. Rubinson L, Nuzzo JB, Talmor DS, O'Toole T, Kramer BR, Inglesby TV. Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: Recommendations of the Working Group on Emergency Mass Critical Care. Crit Care Med. 2005;33:2393-403.
101. Morris SS, Wodon Q. The allocation of natural disaster relief funds: Hurricane Mitch in Honduras. World Dev. 2003;7:1279-89. (Pubitemid 36738681)
102. Fiedrich F, Gehbaur F, Rickers U. Optimized resource allocation for emergency response after earthquake disasters. Saf Sci. 2000;35:41-57.
103. Rawls CG, Turnquist MA. Pre-positioning of emergency supplies for disaster response. Technology and Society. 2009;9:1-9.
104. Pesik N, Keim NE, Iserson KV. Terrorism and the ethics of emergency medical care. Ann Emerg Med. 2001;37:642-6.
105. Fries G, McCalla G, Levitt A, Cordova R. A prospective comparison of paramedic judgment and the trauma triage rule in the prehospital setting. Ann Emerg Med. 1994;24:885-9.
106. White DB, Katz MH, Luce JM, Lo B. Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med. 2009;150:132-8.
107. Department of Health and Human Services. Draft Guidance on Allocating and Targeting Pandemic Influenza Vaccine. Washington, DC: U.S. Department of Health and Human Services; 2007. Available at: www.pandemicflu.gov/vaccine/ prioritization.pdf , http://www.flu.gov/individualfamily/vaccination/ allocationguidance.pdf (Accessed April 14, 2010).
108. Emanuel EJ, Wertheimer A. Public health. Who should get influenza vaccine when not all can? Science. 2006;312:854-5.
109. Williams A. Intergenerational equity: An exploration of the 'fair innings' argument. Health Econ. 1997;6:117-32.
110. Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ. 2006;175:1377-81.
111. Webster RG. Predictions for future human influenza pandemics. J Infect Dis. 1997;176:S14-9.
112. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. Swine influenza viruses: A North American perspective. Adv Virus Res. 2008;72:127-54.